Eupraxia Pharmaceuticals (EPRX) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $6.62, -2.22% vs the prior close of $6.77.
- Volume 582.31K shares, 0.9x its 50-day average.
- New SEC filings: 6-K (Oct 15, 2026).
- No new insider buys or sales reported since the prior session.
EPRX dips 2.2% to $6.62. Closed at $6.62, -2.22% vs the prior close of $6.77. Day range $6.56–$6.87, opened at $6.78.
EPRX daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — EPRX dips 2.2% to $6.62
- Closed at $6.62, -2.22% vs the prior close of $6.77. Day range $6.56–$6.87, opened at $6.78.
- Volume was 582.31K shares, 0.9x its 50-day average of 672.16K.
- Price is -11.7% vs its 50-day average ($7.50) and -9.8% vs its 200-day average ($7.34).
- 52-week range $5.25–$9.32; today's close sits at 34% of that range, 29.0% below the 52-week high.
Oct 15, 2026 — EPRX rises 2.7% to $6.77
- Closed at $6.77, +2.73% vs the prior close of $6.59. Day range $6.49–$6.82, opened at $6.60.
- Volume was 594.90K shares, 0.9x its 50-day average of 662.27K.
- Price is -9.7% vs its 50-day average ($7.50) and -7.9% vs its 200-day average ($7.35).
- 52-week range $5.25–$9.32; today's close sits at 37% of that range, 27.4% below the 52-week high.
- SEC filings that day: 6-K.
Oct 14, 2026 — EPRX dips 1.3% to $6.59, a 1-month low, 5 down days in a row
- Closed at $6.59, -1.35% vs the prior close of $6.68. Day range $6.42–$6.80, opened at $6.59.
- Volume was 278.20K shares, 0.4x its 50-day average of 661.88K — lighter than usual.
- Price is -12.1% vs its 50-day average ($7.49) and -10.4% vs its 200-day average ($7.35).
- 52-week range $5.25–$9.32; today's close sits at 33% of that range, 29.3% below the 52-week high.
- That makes 5 straight losses.
Oct 13, 2026 — EPRX slides 8.7% to $6.68, a 1-month low on 2.4x normal volume
- Closed at $6.68, -8.74% vs the prior close of $7.32. Day range $6.62–$7.29, opened at $7.29.
- Volume was 1.52M shares, 2.4x its 50-day average of 633.40K — unusually heavy trading.
- Price is -10.9% vs its 50-day average ($7.49) and -9.2% vs its 200-day average ($7.36).
- 52-week range $5.25–$9.32; today's close sits at 35% of that range, 28.3% below the 52-week high.
- That makes 4 straight losses.
Oct 12, 2026 — EPRX dips 1.9% to $7.32, 3 down days in a row
- Closed at $7.32, -1.88% vs the prior close of $7.46. Day range $7.25–$7.56, opened at $7.46.
- Volume was 250.70K shares, 0.4x its 50-day average of 637.53K — lighter than usual.
- Price is -2.3% vs its 50-day average ($7.49) and -0.6% vs its 200-day average ($7.36).
- 52-week range $5.25–$9.32; today's close sits at 51% of that range, 21.5% below the 52-week high.
- That makes 3 straight losses.
Oct 9, 2026 — EPRX dips 1.5% to $7.46
- Closed at $7.46, -1.45% vs the prior close of $7.57. Day range $7.28–$7.70, opened at $7.57.
- Volume was 1.05M shares, 1.6x its 50-day average of 638.57K.
- Price is -0.2% vs its 50-day average ($7.47) and +1.4% vs its 200-day average ($7.36).
- 52-week range $5.25–$9.32; today's close sits at 54% of that range, 20.0% below the 52-week high.
- SEC filings that day: 6-K.
Oct 8, 2026 — EPRX dips 2.7% to $7.57
- Closed at $7.57, -2.70% vs the prior close of $7.78. Day range $7.34–$7.75, opened at $7.69.
- Volume was 637.00K shares, 1.0x its 50-day average of 641.53K.
- Price is +1.6% vs its 50-day average ($7.45) and +2.9% vs its 200-day average ($7.36).
- 52-week range $5.25–$9.32; today's close sits at 57% of that range, 18.8% below the 52-week high.
Oct 7, 2026 — EPRX rises 0.5% to $7.78
- Closed at $7.78, +0.52% vs the prior close of $7.74. Day range $7.47–$7.88, opened at $7.64.
- Volume was 853.30K shares, 1.3x its 50-day average of 634.70K.
- Price is +4.8% vs its 50-day average ($7.42) and +5.8% vs its 200-day average ($7.35).
- 52-week range $5.25–$9.32; today's close sits at 62% of that range, 16.5% below the 52-week high.
Oct 6, 2026 — EPRX ends flat (-0.1%) to $7.74 on 2.7x normal volume
- Closed at $7.74, -0.06% vs the prior close of $7.74. Day range $7.67–$8.07, opened at $7.81.
- Volume was 1.64M shares, 2.7x its 50-day average of 608.50K — unusually heavy trading.
- Price is +4.8% vs its 50-day average ($7.39) and +5.4% vs its 200-day average ($7.35).
- 52-week range $5.25–$9.32; today's close sits at 61% of that range, 17.0% below the 52-week high.
Oct 5, 2026 — EPRX jumps 7.0% to $7.74 on 3.0x normal volume
- Closed at $7.74, +6.98% vs the prior close of $7.24. Day range $7.07–$7.93, opened at $7.20.
- Volume was 1.77M shares, 3.0x its 50-day average of 590.85K — unusually heavy trading.
- Price is +5.3% vs its 50-day average ($7.36) and +5.5% vs its 200-day average ($7.34).
- 52-week range $5.25–$9.32; today's close sits at 61% of that range, 16.9% below the 52-week high.
Oct 2, 2026 — EPRX slides 7.5% to $7.24, a 1-month low on 3.1x normal volume
- Closed at $7.24, -7.54% vs the prior close of $7.83. Day range $7.19–$8.09, opened at $8.00.
- Volume was 1.71M shares, 3.1x its 50-day average of 560.42K — unusually heavy trading.
- Price is -1.1% vs its 50-day average ($7.32) and -1.2% vs its 200-day average ($7.33).
- 52-week range $5.25–$9.32; today's close sits at 49% of that range, 22.3% below the 52-week high.
EPRX latest news & SEC filings
Every SEC filing by or about EPRX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 15, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Oct 9, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 30, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 8, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 24, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Aug 19, 2026 · Form F-10/A — F-10/A filing
F-10/A filing
Aug 13, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 11, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 15, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 13, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 7, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade EPRX
- How much it moves: over the last 20 sessions the average daily move was 3.60% (largest 14.0%). That is a volatile stock.
- Liquidity: about 1.02M shares (≈$6.74M) trade per day on average.
- 52-week position: $6.62 vs a range of $5.25–$9.32 (34% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Oct 15, 2026; 6-K Oct 9, 2026; 6-K Sep 30, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
EPRX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 6.78 | 6.87 | 6.56 | 6.62 | 582.31K |
| Oct 15, 2026 | 6.60 | 6.82 | 6.49 | 6.77 | 594.90K |
| Oct 14, 2026 | 6.59 | 6.80 | 6.42 | 6.59 | 278.20K |
| Oct 13, 2026 | 7.29 | 7.29 | 6.62 | 6.68 | 1.52M |
| Oct 12, 2026 | 7.46 | 7.56 | 7.25 | 7.32 | 250.70K |
| Oct 9, 2026 | 7.57 | 7.70 | 7.28 | 7.46 | 1.05M |
| Oct 8, 2026 | 7.69 | 7.75 | 7.34 | 7.57 | 637.00K |
| Oct 7, 2026 | 7.64 | 7.88 | 7.47 | 7.78 | 853.30K |
| Oct 6, 2026 | 7.81 | 8.07 | 7.67 | 7.74 | 1.64M |
| Oct 5, 2026 | 7.20 | 7.93 | 7.07 | 7.74 | 1.77M |
| Oct 2, 2026 | 8.00 | 8.09 | 7.19 | 7.24 | 1.71M |
| Oct 1, 2026 | 8.91 | 9.12 | 7.68 | 7.83 | 3.65M |
| Sep 30, 2026 | 8.33 | 9.21 | 8.12 | 9.10 | 1.28M |
| Sep 29, 2026 | 8.16 | 8.46 | 8.08 | 8.31 | 645.10K |
| Sep 28, 2026 | 7.84 | 8.22 | 7.84 | 8.21 | 369.10K |
| Sep 25, 2026 | 8.19 | 8.30 | 7.86 | 8.01 | 1.31M |
| Sep 24, 2026 | 8.35 | 8.35 | 7.84 | 8.16 | 452.90K |
| Sep 23, 2026 | 8.55 | 8.60 | 7.98 | 8.14 | 662.60K |
| Sep 22, 2026 | 8.77 | 8.77 | 8.39 | 8.58 | 781.70K |
| Sep 21, 2026 | 8.73 | 8.77 | 8.51 | 8.64 | 314.20K |
About Eupraxia Pharmaceuticals
Eupraxia Pharmaceuticals (EPRX) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in VANCOUVER. State of incorporation: British Columbia, Canada. Fiscal year ends December 31. SEC CIK 1581178.
EPRX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
EPRX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
EPRX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on EPRX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.